IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Total liabilities 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) total liabilities at each fiscal year-end, per SEC filings.
$214.6MFY2025 · since FY2016: $5.0M → $214.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $214.6M | +7.3% |
| FY2024 | $200.0M | +2.2% |
| FY2023 | $195.7M | — |
| FY2018 | $14.6M | +47.9% |
| FY2017 | $9.9M | +99.1% |
| FY2016 | $5.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice